Use of Sirolimus-Eluting Coronary Stents in Routine Clinical Practice

Catheterization and Cardiovascular Interventions

Volumn 62, Issue 1, 2004, Pages 26-29

  Goy, Jean Jacques ^a,b   Urban, Philip ^a   Seydoux, Charles ^a   De Benedetti, Edoardo ^a   Stauffer, Jean Christophe ^a  

^a Clinique Cecil   (Switzerland)

^b Clinique Cecil   (Switzerland)

Author keywords

Coronary angioplasty; Drug eluting stents; Percutaneous coronary interventions

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RAPAMYCIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RESTENOSIS; RISK FACTOR; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REOPERATION; SIROLIMUS; STENTS; SWITZERLAND; TREATMENT OUTCOME;

EID: 2342502615     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10744     Document Type: Article

References (10)

1. Serruys P, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med 1994;331:489-495.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study investigators. N Engl J Med 1994;331:496-501.
3. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
4. SoS investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomised controlled trial. Lancet 2002;360:965-970.
5. Goy JJ, Kaufmann U, Goy-Eggenberger D, et al. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Mayo Clin Proc 2000;75:1116-1124.
6. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a Sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
7. Tanabe K, Serruys PW, Grube E, et al. TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003; 107:559-564.
8. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107: 381-383.
9. Grube E, Silber S, Hauptmann K, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
10. Urban P, Serruys P, Baumgart D, et al., for the RENO investigators. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003;24:604-612.